Characteristics and Outcome of Biopsy-proven Malignant Hypertension with Severe Kidney Injury: A Retrospective Study
- PMID: 34880557
- PMCID: PMC8597798
- DOI: 10.4103/ijn.IJN_187_20
Characteristics and Outcome of Biopsy-proven Malignant Hypertension with Severe Kidney Injury: A Retrospective Study
Abstract
Background: Although malignant hypertension begets multiple target organ damage, there is limited data on patients with severe renal injury and evident malignant hypertension in renal histopathology.
Methods: We assessed the baseline demographic, histopathological findings and clinical outcomes in this retrospective analysis of patients with biopsy-proven malignant hypertension.
Results: Thirty cases were analysed, the mean age of patients was 40 ± 11.5 years, 28 (93.3%) were males and the average systolic and diastolic blood pressures at hospitalisation were 197.04 ± 24.14 and 117.41 ± 18.31 mmHg, respectively. Severe retinopathy was seen in 10 (33.3%). The median eGFR at admission was 6.3 (IQR 4.4-9.15) mL/min and 21 (72.4%) needed dialysis. Nine (30%) cases with glomerular crescents were having the primary glomerular disease (7 IgAN, 1 C3 glomerulonephritis, 1 membranoproliferative glomerulonephritis) and 17 (56.6%) had thrombotic microangiopathy. Three-month ESRD free survival was 34.5% (n = 10) and the ESRD cohort had more incidence of dialysis requiring kidney injury at presentation (94.4% vs. 40% in the non-ESRD cohort). Patient survival at 1 year was 50%. Isolated malignant hypertension, differed from others with regard to lesser incidence of severe retinopathy, less glomerular sclerosis (29.61 ± 15.86 vs. 48.45% ± 30.78; P = 0.03), absence of crescents (P = 0.02), more incidence of tuft wrinkling (100% vs. 35%, P = 0.00) and total vessel occlusion (P = 0.02).
Conclusion: Clinicopathologically, accelerated essential hypertension differs from hypertension of glomerular disease. Degree of kidney injury at presentation is risk predictor for long-term morbidity in malignant hypertension.
Keywords: Creatinine; crescent; fibrinoid; malignant hypertension; outcome.
Copyright: © 2021 Indian Journal of Nephrology.
Conflict of interest statement
There are no conflicts of interest.
Similar articles
-
Clinico-pathological characteristics and outcomes of patients with biopsy-proven hypertensive nephrosclerosis: a retrospective cohort study.BMC Nephrol. 2016 Apr 11;17:42. doi: 10.1186/s12882-016-0254-2. BMC Nephrol. 2016. PMID: 27066888 Free PMC article.
-
A Rare Presentation of Immunoglobulin A Nephropathy: Acute Kidney Injury.Nephron. 2017;137(1):8-14. doi: 10.1159/000470852. Epub 2017 Jul 26. Nephron. 2017. PMID: 28743127
-
Clinical outcomes of IgA nephropathy patients with different proportions of crescents.Medicine (Baltimore). 2017 Mar;96(11):e6190. doi: 10.1097/MD.0000000000006190. Medicine (Baltimore). 2017. PMID: 28296731 Free PMC article.
-
Immunoglobulin A nephropathy in association with inflammatory bowel diseases: results from a national study and systematic literature review.Nephrol Dial Transplant. 2022 Feb 25;37(3):531-539. doi: 10.1093/ndt/gfaa378. Nephrol Dial Transplant. 2022. PMID: 33416845
-
[Histopathology of the biopsied kidney and its related glomerular deterioration].Nihon Jinzo Gakkai Shi. 1995 May;37(5):263-70. Nihon Jinzo Gakkai Shi. 1995. PMID: 7609325 Review. Japanese.
References
-
- Shantsila A, Shantsila E, Lip GY. Malignant hypertension: A rare problem or is it underdiagnosed? Curr Vasc Pharmacol. 2010;8:775–9. - PubMed
-
- Van den Born BJ, Koopmans RP, Groeneveld JO, van Montfrans GA. Ethnic disparities in the incidence, presentation and complications of malignant hypertension. J Hypertens. 2006;24:2299–304. - PubMed
-
- Cremer A, Amraoui F, Lip GY, Morales E, Rubin S, Segura J, et al. From malignant hypertension to hypertension-MOD: A modern definition for an old but still dangerous emergency. J Hum Hypertens. 2015;24:1–4. - PubMed
-
- Amraoui F, van Montfrans GA, van den Born BJ. Value of retinal examination in hypertensive encephalopathy. J Hum Hypertens. 2009;4:274–9. - PubMed
-
- Gonzalez R, Morales E, Segura J, Ruilope LM, Praga M. Long-term renal survival in malignant hypertension. Nephrol Dial Transplant. 2010;25:3266–72. - PubMed
LinkOut - more resources
Full Text Sources
Research Materials
Miscellaneous